MedPath

GLAXOSMITHKLINE AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:2
Completed:0

Trial Phases

2 Phases

Phase 3:1
Phase 4:1

Drug Approvals

108

TGA:107
NMPA:1

Drug Approvals

Zanamivir Powder for Inhalation

Product Name
依乐韦
Approval Number
H20140463
Approval Date
Jul 22, 2019
NMPA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (50.0%)
Phase 4
1 (50.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.